Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on May 24th, 2011% Tabernaemontana divaricata (crepe jasmine) flowers
Scientists from the Scripps Research Institute in Jupiter, Florida have synthesized a rare natural product isolated from the bark of a plant widely used in traditional medicine, that has potential as a non-narcotic pain killer. Their findings appear online in the journal Nature Chemistry (paid subscription required).
The . . . → Read More: Non-Narcotic Natural Pain Killer Synthesized
By Alan, on May 24th, 2011% (National Renewable Energy Laboratory)
The Timken Company in Canton, Ohio revealed plans for a new research and development center for wind turbine mechanisms used to generate electricity. The $11.8 million facility, built in collaboration with nearby Stark State College, is expected to add 65 new jobs.
The R&D center will focus on wind . . . → Read More: Timken, College to Build Wind Energy R&D Center
By Alan, on May 23rd, 2011% The solar-powered Lifelight by Lifeline Energy is one of the technologies on the Energy Map (Lifeline Energy)
Santa Clara University in California and social-enterprise information company Ayllu have created the Energy Map Web site that offers graphs and analyses of 40 social enterprises in 16 countries that bring electricity or alternative fuel to . . . → Read More: Interactive Map Shows Off-Grid Energy Technology Sites
By Alan, on May 23rd, 2011% Scientists at Karlsruhe Institute of Technology (KIT) in Germany have transmitted the largest data volume ever on a laser beam, the equivalent of 700 DVDs in one second. The team’s findings appear online in the journal Nature Photonics (paid subscription required).
The KIT scientists, led by electronics professor Juerg Leuthold, encoded data at a rate . . . → Read More: Engineers Set New Laser Data Transmission Speed Record
By Alan, on May 23rd, 2011% (National Institutes of Health)
Eli Lilly and Company in Indianapolis, Indiana has signed agreements with private investors Care Capital and NovaQuest Capital to establish BioCritica Inc., a new biotechnology company. BioCritica will initially focus on the continued U.S. development and commercialization of Xigris — drotrecogin alfa (activated) — Lilly’s medicine for severe sepsis.
. . . → Read More: Lilly Spins Off Biotech to Develop Sepsis Drug
By Alan, on May 23rd, 2011% Luleå University of Technology in Sweden announced plans to start a research center on the production of fuel gas from biomass. The new Swedish Gasification Centre (SFC) on the Luleå campus is expected to have a budget of SEK 540 million (USD 84.7 million) over 10 years.
SFC will combine industry and academic researchers from . . . → Read More: University to Open Biomass Gasification Research Center
By Alan, on May 21st, 2011% The Economic Development Administration (EDA), part of the U.S. Department of Commerce, announced a funding competition to promote the development of regional collections of innovative businesses. The $33 million program, called the Jobs and Innovation Accelerator Challenge, will fund 20 “high-growth industry clusters” that best spell out strategies for meeting opportunities or overcoming obstacles to . . . → Read More: U.S. Regional Industry Cluster Challenge Unveiled
By Alan, on May 20th, 2011% Soybean field (Agricultural Research Service/USDA)
Sygenta, in Basel, Switzerland says it will build a new biotechnology research facility adjacent to its current campus in Research Triangle Park, North Carolina. The $71 million facility is expected to be operational in the second half of 2012.
The company says the new labs will focus on . . . → Read More: Sygenta to Build U.S. Genetics Research Facility
By Alan, on May 20th, 2011% Harvesting fungi from ethanol byproducts (Jeni Maiers/Iowa State University)
A process developed by engineers at Iowa State University in Ames to turn by-products of corn ethanol into into animal feed has moved from the lab to a pilot plant. The process, called MycoMeal, developed by engineering professor Hans van Leeuwen and his team, . . . → Read More: Ethanol By-Product Reprocessing Expands to Pilot Stage
By Alan, on May 20th, 2011% (Photos8.com)
The U.S. Food and Drug Administration approved today the drug Edurant (rilpivirine) as a treatment for HIV infection in adults, when used in combination with other antiretroviral drugs. Edurant is manufactured by Tibotec Therapeutics, a subsidiary of Johnson & Johnson, in Raritan, New Jersey.
FDA approved the drug for the treatment of . . . → Read More: FDA Approves HIV Drug in Combination Treatment
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.